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ABSTRACT
Recently, Type III-A CRISPR-Cas systems were found
to catalyze the synthesis of cyclic oligoadenylates
(cOAs), a second messenger that specifically acti-
vates Csm6, a Cas accessory RNase and confers an-
tiviral defense in bacteria. To test if III-B CRISPR-Cas
systems could mediate a similar CRISPR signaling
pathway, the Sulfolobus islandicus Cmr- ribonucle-
oprotein complex (Cmr-–RNP) was purified from the
native host and tested for cOA synthesis. We found
that the system showed a robust production of cyclic
tetra-adenylate (c-A4), and that c-A4 functions as a
second messenger to activate the III-B-associated
RNase Csx1 by binding to its CRISPR-associated
Rossmann Fold domain. Investigation of the kinet-
ics of cOA synthesis revealed that Cmr-–RNP dis-
played positively cooperative binding to the adeno-
sine triphosphate (ATP) substrate. Furthermore, mu-
tagenesis of conserved domains in Cmr2 confirmed
that, while Palm 2 hosts the active site of cOA syn-
thesis, Palm 1 domain serves as the primary site in
the enzyme–substrate interaction. Together, our data
suggest that the two Palm domains cooperatively in-
teract with ATP molecules to achieve a robust cOA
synthesis by the III-B CRISPR-Cas system.
INTRODUCTION
CRISPR-Cas systems provide a heritable adaptive immu-
nity against the invasion of viruses and plasmids in prokary-
otes. The antiviral immunity is achieved in three steps: first,
a short fragment (protospacer) of an invading nucleic acid
is recognized and acquired as a new spacer in a CRISPR
locus (1–3); second, CRISPR loci are transcribed, yielding
precursor CRISPR RNAs (crRNAs) that are further pro-
cessed into mature crRNAs (4) and finally, crRNAs gen-
erated from the new spacer form ribonucleoprotein com-
plexes (RNPs) with Cas proteins, and the resulting RNPs
recognize invading nucleic acids by sequence complemen-
tarity to the corresponding protospacer on recurring inva-
sive genetic elements and target them for destruction (5).
CRISPR-Cas systems are classified into six different types
(Type I–VI) based on their gene synteny and mechanisms
of interference (6,7). These antiviral systems have evolved
distinct mechanisms of recognition and destruction of in-
vading nucleic acids. Among them, Type I, II and V sys-
tems target double-stranded DNA, and the interference ac-
tivity is dependent on a shortmotif flanking the protospacer
(known as protospacer adjacent motif ), while Type VI sys-
tems bind to the target RNA that complements the crRNA
and are activated for indiscriminate RNA degradation (8–
12).
Investigation of CRISPR-Cas10 (Type III) systems has
revealed that mechanisms of their nucleic acid interference
are very different from those of all other known CRISPR-
Cas systems. Two subtypes have been characterized in de-
tail, including III-A Csm and III-B Cmr systems. Early
studies showed that the Staphylococcus epidermidis Csm
(SeCsm) system mediates DNA interference (13,14), while
the Pyrococcus furiosus Cmr (PfCmr) effector complex ex-
hibits RNA cleavage activity (15). Further studies show that
Type III effector complexes cleave target RNA in 6-nt in-
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tervals (16–21), and the active site is located in Cmr4 or
Csm3, the large backbone subunit of each subtype system
(18,21,22). Strikingly, investigation of theSulfolobus islandi-
cus Cmr- (Cmr-) system by an invader plasmid assay re-
vealed that it mediates transcription-dependent DNA in-
terference (23), and the system shows dual DNA/RNA in-
terference (23,24). Subsequently, the same activities were
found for other Type III systems (25–27). Furthermore, in
vitro characterization of both Csm and Cmr effector com-
plexes showed that they all possess target RNA-activated
DNA cleavage activity (28–32). In addition, the Sulfolobus
solfataricus III-D (SsCsm) systemwas shown to cleave plas-
mid DNA targets in vitro (33). As recently reviewed (34–
36), all investigatedType III systems exhibitmultiple nucleic
acid interference activities, including the backbone RNA
cleavage, the target RNA-activated DNA cleavage, in which
the former activity relies on the nuclease domain of the large
backbone subunit, while the latter depends on the HD nu-
clease domain of the Cas10 subunit (Csm1 or Cmr2).
More recently, it was reported that Csm–RNPs of Strep-
tococcus thermophilus (StCsm) and Enterococcus italicus
(EiCsm) catalyze the synthesis of cyclic oligoadenylates
(cOAs) (37,38). Upon the binding of the cognate target
RNA to a binary Csm–RNP complex, the Palm 2 (or cy-
clase) domain of the Csm1 subunit in these RNPs is acti-
vated for cOA synthesis. The resulting cOAs function as a
second messenger that binds the CRISPR-associated Ross-
mann Fold (CARF) domain of Csm6, a Cas accessory ri-
bonuclease, and activates its RNase activity from the higher
eukaryotes and prokaryotes nucleotide-binding (HEPN)
domain (37,38). Consistent with these results, csm6 is es-
sential for the prevention of plasmid transfer and virus mul-
tiplication by SeCsm in S. epidermidis and Staphylococcus
aureus, respectively (39,40). To date, the synthesis of cOA
second messenger and the CRISPR signaling remain to be
investigated for Type III-B CRISPR-Cas systems.
We have employed S. islandicusRey15A (41) as themodel
to investigate molecular mechanisms of III-B CRISPR-Cas
systems. The organism contains a complete I-A system in-
cluding an adaptation module, an interference module and
two CRISPR arrays as well as two disparate III-B Cmr
modules (Cmr- and Cmr-), among which the last two
systems are not located in a close neighborhood to any
CRISPR array (42). Nevertheless, both Cmr systems can
utilize crRNAs produced from the I-A CRISPR arrays and
mediate nucleic acid interference (23,24,43). Furthermore,
the S. islandicus Cmr- ribonucleoprotein complex (Cmr-
–RNP) cleaves target RNAs by the large backbone sub-
unit Cmr4 and performs single-stranded DNA (ssDNA)
degradation upon binding to the cognate target RNA (31),
and Cmr1 facilitates the dual DNA/RNA cleavage by in-
teracting with the target RNA (44). On the other hand,
cmr-α genes are clustered with csx1 (23) encoding a Cmr-
associated CARF domain RNase (45). The CARF domain
of the enzyme was found to bind to 3′-tetradenylates and
the interaction strongly activates the Csx1 RNase activity
(46).
In this study, we demonstrated that the CRISPR sig-
naling pathway is evolutionarily conserved in Type III-B
CRISPR-Cas systems since Cmr-–RNP converts adeno-
sine triphosphate (ATP) to cyclic tetraadenylate (c-A4) that
also functions as a second messenger to activate the RNase
activity of Csx1. Characterization of the catalysis of cOA
synthesis by Cmr-–RNP further revealed that the enzyme
displays robust cOA synthesis, probably resulting from the
cooperative substrate binding in enzyme–substrate interac-
tion.
MATERIALS AND METHODS
Construction of pAC-cmr2 and its derivatives and purifica-
tion of Cmr-–RNPs from S. islandicus
The cmr2 gene (SiRe 0894) was amplified from S. islandi-
cus REY15A (42) by polymerase chain reaction (PCR) us-
ing FastPfu DNA polymerase (TransGene, Beijing China)
with the primer set of Cmr2-up-NheI and Cmr2-dw-SalI
(Supplementary Table S1). The resulting PCR fragment was
digested with NheI and SalI and inserted into the same sites
on pSeSD1 (47), giving pCmr2 plasmid (Supplementary
Table S3). Then, the cmr2 expression cassette on pCmr2
was amplified by PCR, using the primer pair of MRS-up
andMRS-dw (Supplementary Table S1), including the arti-
ficial arabinose-inducible promoter araS-SD, the coding se-
quence of 6×His-tag, and that of cmr-2 plus the transcrip-
tional terminator. The resulting PCR product was digested
with SmalI and XhoI and insertion of the expression cas-
sette into the SmaI and SalI sites on pAC-MS1 (31) yielded
pAC-cmr2 (Supplementary Figure S1).
Mutated cmr2 genes carrying substitutions in the HD,
Palm 1 or Palm 2 domain were generated by splicing, over-
lapping and extension PCR (SOE-PCR) following the pub-
lished procedure (48), using the primers listed in Supple-
mentary Table S1. Specifically, the first DNA fragment
(Cmr2HD-L, Cmr2P2-L or Cmr2P1-L) was generated by
PCR using MRS-up and one of the following primers:
Cmr2HD-L-dw, Cmr2P2-L-dw or Cmr2P1-L-dw, whereas
the second DNA fragment (Cmr2HD-R, Cmr2P2-R or
Cmr2P1-R) was obtained by PCR using the primer combi-
nation of MRS-dw with one of the following: Cmr2HD-R-
up, Cmr2P2-R-up or Cmr2P1-R-up. PCR fragments con-
taining mutated HD, P1 or P2 domain were obtained by
PCR using the primer set of MRS-up and MRS-dw, with
the corresponding PCR fragment as DNA template (i.e.
Cmr2HD-L+R, Cmr2P2-L+R or Cmr2P1-L+R). The re-
sulting SOE-PCR fragments were digested with SmalI and
XhoI, and ligation of each restricted SOE-PCR fragment
with SmaI+SalI-digested pAC-MS1 yielded pAC-cmr2-
HD, pAC-cmr2-P1 and pAC-cmr2-P2 individually. All
mutations were confirmed by determination of DNA se-
quences of the constructed plasmids. Each plasmidwas then
electroporated into S. islandicusMF1 (31) as previously de-
scribed, giving transformants that were suitable for Cmr-–
RNP purification.
To purify Cmr-–RNPs carrying substitution mutations
in HD, Palm 1 or Palm 2 domain, these transformants
were grown in SCV media (Basal media supplemented with
0.2% sucrose, 0.2% Casamino acids and 1% vitamin solu-
tion) at 78◦C (41). When cultures were grown to A600 =
0.7, cell mass was harvested and used for Cmr-–RNP pu-
rification as previously described (31,49). Briefly, cell pel-
lets were resuspended in Buffer A (20 mM hydroxyethyl-
piperazineethane-sulfonic acid (HEPES) pH 7.5, 30 mM
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Imidazole, 500 mM NaCl), giving cell suspensions that
were treated by French press to disrupt cells. Each result-
ing cell extract was loaded onto a 1 ml HisTrap HP column
(GE Healthcare, Waukesha, WI, USA). The Cmr- effec-
tor complex was purified by stepwise elution with buffers
containing 30, 70 and 200 mM imidazole successively. Frac-
tions containing the target protein were concentrated and
further purified by size exclusion chromatography (SEC) in
Buffer C (20 mM Tris–HCl (pH 7.5), 250 mMNaCl), using
a Superdex 200Hiload column (GEHealthcare,Waukesha,
WI, USA). Sample fractions collected during SEC were an-
alyzed by sodium dodecylsulphate-polyacrylamide gel elec-
trophoresis and those containing the complete set of Cmr-
componentswere pooled together and used for further anal-
ysis.
Conversion of ATP to cyclic oligoadenylates (cOAs) by Cmr-
–RNP
Biochemical assay for testing ATP conversion by Cmr-–
RNP consisted of the following components, including 5
mM MgCl2, 5 mM DTT, ∼1 nM 32P-ATP (PerkinElmer,
Waltham, MA, USA), 80 nM SS1-46, 100 MATP and 40
nM Cmr-–RNP in 20 mM Mes (pH 6.0). The assay was
conducted at 70◦C for 20 min, and the reaction was stopped
by addition of 10 l 2×RNA loading dye. After denaturing
by heating to 95◦C for 2min and cooling on ice for 5min, all
samples were analyzed by denaturing 24% polyacrylamide
gel electrophoresis (PAGE). Labeled nucleotides were de-
tected by exposing the gel to a phosphor screen and scanned
with a Typhoon FLA 7000 (GEHealthcare,Waukesha,WI,
USA).
Liquid chromatography and mass spectrometry (LC-MS)
analysis
A 100 l ATP reaction was set up as described above ex-
cept for the omission of 32P-ATP. The reaction mixture
was incubated at 70◦C for 20 min. After inactivation of the
enzyme by incubation at 95◦C for 5 min and subsequently
cooling down on ice, the reaction mixture was loaded onto
a Kinetex EVO C18 column (100 × 2.1 mm, 1.7 m) (Phe-
nomenex, Torrance, CA, USA), which was pre-equilibrated
with buffer A (5 mM ammonium acetate) at 30◦C at 0.3
ml/min. The products were purified by stepwise elution
with different concentrations of buffer B (100% acetoni-
trile): 0–2 min, 0% buffer B; 2–22 min, 20% buffer B; 22–25
min, 50% buffer B, 25–29 min 100% buffer B.
Electrospray ionization mass spectrometry data were
acquired using a micrOTOF-QII (Bruker, Billerica, MA,
USA) in MS Scan mode from 100 to 2000 m/z in the nega-
tive ionizationmode. The employed ESI parameters were as
following: Cappilary voltage: 4.5 kV; End plate offset: -500,
Nebulizer: 1.2 Bar, Dry Heater: 200◦C, Dry Gas: 9 L/min,
collision cell RF: 800 Vpp.
Nuclease S1 degradation analysis
To visualize the degradation of ATP reaction product, ∼50
nM labeled ATP reaction product was incubated with 0.2
U/l Nuclease S1 (Thermo Fisher Scientific, Waltham,
MA, USA) in a 10-l mixture containing 2 l 5× reaction
buffer at 37◦C. The reactions were stopped by supplement-
ing 2×RNA loading dye at indicated time points and stored
on ice. Then, all samples were analyzed denaturing PAGE
in a 24% gel with results recorded by phosphor imaging as
described above.
Enzymatic probing of nucleotide products produced by Cmr-
–RNP
T4 polynucleotide kinase (PNK; New England Biolabs,
Ipswich, MA, USA), Fast alkaline phosphatase (FastAP;
Thermo Fisher Scientific, Waltham, MA, USA) and
poly(A) polymerase (PAP; New England Biolabs, Ipswich,
MA, USA) were employed for the characterization of ATP
reaction products. Aliquots of the labeled cOAswere treated
with each enzyme by following the instruction from their
manufacturers. All reactions were performed in a 10-l
mixture containing ∼50 nM labeled ATP reaction prod-
uct and 1 l of each enzyme. The enzyme treatments were
conducted at 37◦C for 60 min and analyzed by denaturing
PAGE in a 24% PA gel with results recorded by phosphor
imaging.
To further investigate whether the ATP reaction products
could be modified, reaction mixtures (in 10 l) were set up
in Buffer A (50 mM Tris–HCl, pH 7.6, 10 mM MgCl2, 5
mM Dithiothreitol (DTT), 0.1 mM spermidine) with the
following components: (i) ∼100 nM ATP reaction product
from each liquid chromatography fraction collected from
the two predominant peaks (Figure 2A), (ii) 1 U/l T4
PNK and (iii) 1 nM  32P-ATP. After incubation at 37◦C
for 60 min, all treated samples were analyzed by denatur-
ing PAGE in a 24% gel, with the ATP reaction product
generated with 32P-ATP as a reference. The results were
recorded by phosphor imaging.
Nucleic acid cleavage by the wild-type and mutated Cmr-
effector complexes
Radio-labeled SS1-40 RNA and S10 ssDNA (Supplemen-
tary Table S2) were substrate for the backbone RNA cleav-
age and the target RNA-activated ssDNA cleavage, re-
spectively. These nucleic acids were synthesized from Inte-
grated DNATechnologies (IDT, Coralville, IA, USA.), gel-
purified and 5′ labeled with  32P-ATP using T4 PNK (New
England Biolabs, Ipswich, MA, USA) as described previ-
ously (31).
Backbone RNA cleavage was assayed in a 10-l reaction
mixture containing 50mMTris-Cl (pH 7.5), 10mMMgCl2,
5 mM DTT, 20 nM of labeled SS1-40 and 20 nM of the
wild-type or one of the mutated Cmr-–RNP as specified
in each experiment. The cleavage was conducted at 70◦C for
20min, and the reaction was stopped by addition of 10l of
2× RNA loading dye. After heating to 95◦C for 2 min and
cooling down on ice for 5 min, RNA cleavage was analyzed
by denaturing PAGE in a 18% gel with the results recorded
by phosphor imaging.
The DNA cleavage assay was conducted in a 10-l re-
action mixture contains 50 mM Tris-Cl (pH 7.5), 10 mM
MgCl2, 5 mMDTT, 200 nM SS1-46, 20 nM labeled S10-60
ssDNA and 20 nM of the wild-type or a mutated Cmr-–
RNP. The mixtures were incubated at 70◦C for 60 min and
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analyzed as described for the backbone RNA cleavage as-
say.
Csx1 RNA cleavage assay
Csx1 RNA cleavage was assayed in a 10-l reaction mix-
ture containing 20 mMMes (pH 6.0), 5 mM DTT, 500 nM
unlabeled SS1-40, 20 nM labeled SS1-40, 100 nM Csx1 or
one of its mutants in the presence of c-A4, the circular lig-
and, or CAAAA, the linear ligand. Reaction mixtures were
incubated at 70◦C for 20 min and analyzed as described for
the backbone RNA cleavage assay.
Csx1 ligand binding assay
The affinity of Csx1 to two ligands, c-A4 and CAAAA,
was analyzed using electrophoretic mobility shift assay
(EMSA). The assay was set up in a 10-l reaction mix-
ture containing 20 mMMes (pH 6.0), 8% glycerine, 50 mM
DTT, 50 nM labeled c-A4 or CAAAA, and a series of dif-
ferent concentrations of Csx1 or one of its mutants as indi-
cated in each experiment. Reactionmixtures were incubated
at 70◦C for 10 min and analyzed by non-denaturing PAGE
in a 10% gel, and the results were recorded by phosphor
imaging.
Cmr- substrate-binding assay
Interaction between ATP and Cmr-–RNP, or one of the
mutated effector complexes was analyzed by EMSA. The
basic binding reaction contained 200 nM Cmr- (or a mu-
tant effector complex) and 1 nM  32P-ATP to which 1 mM
ethylenediaminetetraacetic acid (EDTA) or 5 mM MgCl2
was added. The resulting mixtures were incubated at 70◦C
for 10 min. The effect of target RNA on Cmr- ATP bind-
ing was evaluated by addition of 300 nM SS1-46 into the
mixtures and further incubated for 3 min at 70◦C. Samples
were then analyzed by non-denaturing PAGEon 10%gels in
0.5× TB electrophoresis buffer (45 mM Tris-borate). ATP–
Cmr-–RNP complexes were detected as for the analysis of
Csx1–ligand interaction described above.
Kinetic study of ATP incorporation by Cmr-–RNP
Kinetics of the ATP reaction by Cmr-was determined in a
mixture containing 20 mMMes 9 (pH 6.00), 5 mMMgCl2,
5 mM DTT, 200 nM SS1-46 RNA and ∼1 nM 32P-ATP
(PerkinElmer), with the concentrations of Cmr- and ATP
specified in the experiments. After incubation at 70◦C for
5 min, the reactions were analyzed by denaturing PAGE
in a 24% gel and ATP reaction products were quantified
by ImageQuant TL 8.1 (GE Healthcare, Waukesha, WI,
USA). The ATP incorporation rate was calculated as the
amount of incorporated ATP (M) per min. To ensure the
experiments could reflect the initial reaction rate, different
amounts of the Cmr- effector complex were supplemented
into the reactions so that the percentage of incorporated
ATPwas always<30% of the total substrate. Four nanomo-
lar of Cmr- was assayed for the ATP reaction with 5–1500
M substrate, with the resulting data used for simulation
to fit the Michaelis–Menten model (Equation 1). Hill plot
analysis was conducted with two datasets using the simpli-
fied Hill plot model (Equation 2): (i) ATP reaction products
produced by 20 nMCmr- in the presence of 1–10 Msub-
strate and (ii) ATP reaction products produced by 80 nM
Cmr- in the presence of 0.02–1 M of substrate. The sim-
ulation was performed by using OriginPro 2017 software
(OriginLab Co., Northampton, MA, USA).
V = Vmax [S]
Km + [S] (1)
log (V) = nlog [S] − logKd + logVmax (2)
Equation (2) represents a simplified Hill plot model
(Equation 3) (50), in which it is assumed that, when the V
value is very low in reference to Vmax, ‘Vmax − V’ can be
regarded as equal to ‘Vmax’.
log
(
V
Vmax − V
)
= nlog [S] − logKd (3)
In Equations (2) and (3), ‘n’ represents the Hill coef-
ficient, reflecting the extent of cooperativity in substrate
binding by an enzyme with multiple binding sites (51).
RESULTS
Activation of cyclic tetra-adenylate (c-A4) synthesis by bind-
ing of the cognate target RNA to Cmr-–RNP
Recently, two III-A Csm–RNPs were shown to catalyze
cOA synthesis with ATP as the substrate, and the ATP con-
version reaction requires the formation of a tertiary Csm
complex between Csm–RNP and the cognate target RNA,
andmismatches between the 5′-repeat handle of the crRNA
and the corresponding 3′ region of the cognate target RNA
(37,38). To test if the cOA synthesis could be evolutionarily
conserved in III-B Cmr–RNPs, we purified the native Cmr-
–RNP that only contained crRNAs derived from the lacS
SS1 spacer. The purified Cmr-–RNP was then tested for
ATP conversion (see ‘Materials and Methods’ section) in
presence of one of the following RNAs: (i) SS1-46 (the cog-
nate target RNA), (ii) SS1-50 (target RNA fully comple-
mentary to SS1 crRNA), (iii) SS1-40 (a target RNA lack-
ing the 3′-flanking sequence corresponding to the crRNA
repeat handle) and (iv) S10 RNA, a non-target RNA to
the Cmr-–RNP complex. All four reaction mixtures were
incubated at 70◦C for 20 min and subjected to denaturing
PAGE to detect ATP reaction products. A single predomi-
nant product was observed only in the presence of SS1-46,
which was absent from the remaining three reactions (Fig-
ure 1A). These results indicated that only the cognate RNA
target that carries a non-complementary 3′-flanking region
has the capability to activate the binaryCmr-–RNP for the
generation of the ATP reaction product.
The metal ion dependence of the ATP reaction was then
investigated by replacement of Mg2+ with one of the fol-
lowing divalent metal ions in the reaction, including Mn2+,
Zn2+, Co2+, Ni2+, Cu2+ and Ca2+. We found that Mg2+,
Mn2+, Zn2+ and Co2+ strongly facilitated the ATP reaction,
Ni2+ showed a lower efficiency, but Cu2+ and Ca2+ failed to
facilitate the ATP reaction (Supplementary Figure S2).
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Figure 1. Cmr--mediated ATP conversion and its regulation. (A) Cmr-
converts ATP to a dominant product upon binding to target RNA. The
Cmr- complex (40 nM) was incubated with 1 nM 32P-ATP and 100 M
ATP in the presence of different RNA oligos (80 nM) and then the sam-
ples were analyzed with denaturing gel electrophoresis. The interactions
of the Cmr- complex with different RNA oligos are depicted above the
gel. The 5′-handle of crRNA, the spacer sequence of crRNA and the sup-
plemented RNA oligos are shown in red, black and blue, respectively. (B)
Pre-incubation of Cmr- and target RNA abolishes the ATP reaction. The
Cmr- complex (40 nM) and SS1-46RNA (40 nM)were pre-incubated un-
til 1 nM 32P-ATP and 100 MATP were supplemented into the reaction
mixture at indicated delay time points. Then, the samples were further in-
cubated for 20 min, followed by analysis of denaturing gel electrophoresis.
Early studies also showed that the cleavage of the cognate
target RNA inactivates the DNase activity of CRISPR-
Cas10 systems (28–30), and more recently, the cOA synthe-
sis by Csm–RNPs (37). To investigate if the target RNA reg-
ulation could also apply to the ATP reaction by Type III-B
systems, the Cmr-–RNP was incubated at 70◦C with SS1-
46 for 5–40 min (pre-incubation). Then, ATP was added
to the mixtures to initiate the ATP reaction. After incuba-
tion at the same temperature for additional 20 min, ATP
reaction products were analyzed by denaturing PAGE and
quantified. As shown in Figures 1B, 5 min pre-incubation
reduced the production of the main product by the Cmr-
complex (indicated by an arrowhead) by 87%, i.e. exhibiting
13% whereas 10 min pre-incubation basically abolished the
ATP reaction. Since these results are in agreement with the
target RNA cleavage profile by the same effector complex,
which reached the equilibrium within 10 min (Supplemen-
tary Figure S3) (31), we concluded that the mechanism of
the inactivation of the ATP reaction by target RNA cleav-
age is conserved in III-A and III-B CRISPR-Cas systems.
LC-MS was then used to determine the molecular weight
(MW) of theATP reaction products, and this revealed a pre-
dominant product (>70%) with a MW of 1315.2 Da, cor-
responding either to cyclic tetra-adenylate (c-A4) or to lin-
ear A4 containing the terminal 2′, 3′-cyclic phosphate and
5′-hydroxyl group (A4>p) and a minor product of a MW
of 986.2 Da matching to either cyclic tri-adenylate (c-A3)
or the corresponding linear A3 (A3>p) (Figure 2A). Esti-
mation of MW of these products by denaturing PAGE re-
vealed that the product migrated more slowly than a 5-nt
RNA marker in the gel (Figure 2B), a characteristic that is
compatible with the circular form of oligoadenylates (c-A3
and c-A4) but incompatible with their corresponding linear
form (A4>p or A3>p), in analogy to the results reported
for the ATP reaction products of StCsm-RNP (37).
To further demonstrate that the ATP reaction products
should be circular, the products were treated with a polynu-
cleotide kinase, a poly(A) RNA polymerase or an alkaline
phosphatase to probe reactive chemical groups both at the
5′- and the 3′-position. Aliquots of the reaction products
were mixed with each of the enzymes individually and incu-
bated as described in ‘Materials and Methods’ section, and
the treated samples were analyzed by denaturing PAGE. As
shown in Figure 2B, none of the three enzymes could mod-
ify the tri- or tetra-adenylate, indicating that these products
do not have any free hydroxyl or phosphate groups at the
5′- and 3′-position. Moreover, labeling of purified products
(obtained from Peak 1 and 2 in Figure 2A) by T4 polynu-
cleotide kinase with  32P-ATP failed to yield any labeled
products (Figure 2C), further confirming the absence of any
5′-hydroxy group from the reaction products. In addition,
testing the presence of the 3′-5′ phosphodiester bond in the
OAs product by S1 nuclease digestion (52) revealed that the
products were readily degraded by the enzyme (Figure 2B).
Altogether these data indicated that the oligonucleotides
synthesized by Cmr-–RNP are c-A3 and c-A4 containing
3′-5′ phosphodiester bonds.
Cyclic tetra-adenylate activates the Csx1 RNase by interac-
tion with the CARF domain
In III-A CRISPR-Cas10 systems, c-A6 functions as a sec-
ond messenger to activate Csm6 (37,38), a Cas accessory
protein belonging to the Csm6/Csx1 superfamily of Cas
accessory proteins (53). Proteins of this superfamily carry
an N-terminal CARF domain predicted for ligand binding
(45) and a C-terminal HEPN nuclease domain (54). The
corresponding member in the S. islandicus Cmr- system
is Csx1 (45,55). The S. islandicus Csx1 was found to play
a role in invader DNA silencing by the III-B DNA inter-
ference in vivo (23). In addition, the Csx1–CARF domain
was found to bind to tetraadenylate, and the interaction
strongly activates the nuclease activity from its HEPN do-
main (46). To test if c-A4 synthesized by Cmr- could also
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/46/19/10319/5103948 by R
oyal Library C
openhagen U
niversity user on 05 N
ovem
ber 2018
10324 Nucleic Acids Research, 2018, Vol. 46, No. 19
Figure 2. Identification of theCmr--mediatedATP reaction products. (A) Liquid chromatography (upper panel) andmass spectrometry (two lower panels)
analysis of the ATP reaction products by Cmr-; *: the peak showing aMWof 657.10 in theMS analysis was also present in the reference sample; **: peak
3 with a MW of 1315.22 could be the tail of the main peak. (B) The ATP reaction product (∼40 nM) was treated with 1 U/l PNK, 0.05 U/l poly(A)
polymerase (PAP), 0.1 U/l alkaline phosphatase (FastAP) and 0.2 U/l Nuclease S1, respectively, followed by analysis of denaturing gel electrophoresis.
The reactions with PNK, PAP and FastAPwere incubated at 37◦C for 60min and the S1 nuclease incubation time was indicated above the gel. If applicable,
1 mM ATP was supplemented into the reaction mixture. (C) The fractions of the peaks from Figure 2A (1: peak 1; 2: peak 2) were labeled with 32P-ATP
by PNK. The ATP reaction product generated with 32P-ATP was also loaded as size marker (the first lane).
activate Csx1 in the same fashion, 520 nM of SS1-40 RNA
substrate was incubated with 100 nM Csx1 with increasing
concentrations of c-A4 for 20 min. All samples were then
analyzed by denaturing PAGE. As shown in Figure 3A, c-
A4 strongly activated the RNA cleavage activity of Csx1.
The extent of Csx1 RNase activation by c-A4 and CAAAA
was estimated by quantification of residual substrates, and
comparison of the resulting data revealed a ∼3.7-fold dif-
ference (Figure 3A and Supplementary Figure S4A). These
results indicated that the circular ligand is a better activator
to Csx1 RNase than the linear one.
To gain an insight into the enhanced Csx1 activation
by c-A4, the binding of each ligand to Csx1 was inves-
tigated by EMSA. We found that both ligands formed a
complex of large molecular weight (Supplementary Figure
S4B). These complexes (Csx1–c-A4 and Csx1–CAAAA)
were then quantified, and the resulting data were then plot-
ted against Csx1 concentrations. This revealed that, al-
though the interaction between Csx1 and each ligand was
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Figure 3. c-A4 activates the RNA cleavage activity of SisCsx1 by binding to its CARF domain. (A) Activation of SisCsx1 RNA cleavage by c-A4 and a
linear poly(A) oligo (CAAAA). The non-cleaved RNA substrate was quantified after incubation with SiCsx1 in the presence of increasing concentrations
of c-A4 or CAAAA. Error bar represents S.D. of three independent experiments. The EC50 value determined for c-A4 and CAAAA is 7.4 and 27.3 nM,
respectively. (B) Comparison of the binding affinity of SisCsx1 to c-A4 andCAAAA. The two ligands were incubation with 0.16, 0.5, 1.5 and 4.5MSiCsx1
and analyzed by non-denaturing PAGE. The percentage of bound ligand was calculated. Error bar represents S.D. of three independent experiments. (C)
Schematic of SisCsx1 domain structure. Conserved amino acid residues subjected to mutagenesis are indicated, including one HEPN domain mutant (M1:
R399A-H404A) and three CARF domain mutants (M2: G95L-A97L-A99L, M3: D50L-S51L and M6: H154L). (D) RNA substrate was incubated with
the wild-type SisCsx1 or each mutant in the presence of 100 nM c-A4, followed by analysis of denaturing PAGE. (E) Labeled c-A4 was incubated with the
wild-type and mutated SisCsx1 proteins, followed by analysis of non-denaturing PAGE.
weak, the enzyme showed ∼4–10-fold higher affinity to c-
A4 than to CAAAA (Figure 3B). Therefore, the better in-
teraction between c-A4 and Csx1 could be accounted for
the elevated level of Csx1 RNase activity with the circular
ligand (Figure 3A).
Then, the Csx1 mutants of the CARF or HEPN domain
previously constructed (M1, M2, M3 and M6, Figure 3C)
(46) were tested forRNAcleavage and their interactionwith
the c-A4 ligand. This showed that: (i) none of the CARF
mutants were active in RNA degradation in the presence
of 100 nM c-A4 (Figure 3D), neither were they capable of
binding to the c-A4 ligand (Figure 3E), and (ii) M1, the
HEPN domain mutant retained the c-A4 binding activity
(Figure 3E). Therefore, albeit c-A4 is a more efficient ligand
for Csx1 activation, both the circular and the linear ligands
interact with the CARF domain of the enzyme and alloster-
ically regulate the enzyme activity from the HEPN domain.
Cmr-–RNP-mediated ATP reaction is characterized by co-
operative substrate binding
Kinetics of the ATP reaction was then investigated by incu-
bation of 4 nMCmr-–RNPwith a large range of ATP con-
centrations (5–1500 M), and the resulting products were
analyzed by denaturing PAGE and quantified (Supplemen-
tary Figure S5A). The ATP incorporation rates (V) were
calculated for all tested substrate concentrations [S] and
plotting of the former against the latter yielded the enzyme
kinetic data that were fitted into the Michaelis–Menten
equation as described in ‘Materials and Methods’ section.
The simulation revealed a Vmax of 5.21 ± 0.22 M/min
with a Km value of 233.40 ± 33.04 M, suggesting a ro-
bust ATP incorporation by Cmr-–RNP (Figure 4A). Nev-
ertheless, changing both V and [S] into a logarithmic scale
revealed that the relationship of V and [S] did not fit into
the Michaelis–Menten equation in the low substrate range
(Figure 4B).
To yield a further insight into howCmr-–RNP catalyzes
the ATP incorporation at low substrate concentrations, we
analyzed the ATP incorporation rate of 20 nM Cmr-–
RNP with 1∼10 MATP and that of 80 nM Cmr-–RNP
with 0.02∼1 MATP, respectively. Plotting of V versus [S]
revealed that the two factors exhibit a polynomial relation-
ship in both experiments (Figure 5A and B; Supplementary
Figure S5B and C). To test if the data could meet a cooper-
ative binding model, we fitted the data to a simplified Hill
plot model as described in ‘Materials andMethods’ section
and estimated their Hill coefficient, a value that reflects the
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Figure 4. Michaelis–Menten modeling of the ATP reaction by Cmr-–
RNP. (A) Four nanomolar Cmr– was incubated with increasing concen-
trations of ATP and the ATP incorporation rate (V) was plotted to the sub-
strate concentration [S] (blue line). Error bar represents S.D. of three inde-
pendent experiments. The V versus [S] relationship was further fitted into
the Michaelis–Menten model (red line). F-test shows the P value <0.001
for the simulation. (B) The curves from (A) are shown in a logarithmic
scale.
extent of cooperativity in substrate binding by a multiple
substrate-binding enzyme (51). The analyses revealed that
theHill plot simulation was almost perfect, with an ‘n’ value
of 2.33± 0.027 for the 80 nMCmr- data, and 2.42± 0.056
for the 20 nM Cmr- data (Figure 5C). Considering that
the Hill coefficient never exceeds 2.1 in the absence of posi-
tive cooperativity in previous simulations (51), these results
indicated that Cmr--mediated c-A4 synthesis exhibits the
feature of cooperative substrate binding.
Cmr- only binds to ATP in the presence of divalent metal
ions
Since both target RNA and divalent metal ions are essential
for the Cmr--mediated ATP reaction (Figure 1A and Sup-
plementary Figure S2), we set to analyze whether both fac-
tors could have a role in the enzyme–substrate interaction.
The experiments were conducted as described in ‘Materi-
als andMethods’ section. This revealed that, whereasMg2+
facilitated the binding of ATP to Cmr-, the target RNA
did not show any influence to the enzyme–substrate interac-
tion (Figure 6A). We also found that binding of metal ions
to Cmr- is required, but not sufficient, for cOA synthesis,
since Ca2+ and Ni2+ facilitated the enzyme–substrate inter-
action (SupplementaryFigure S6) but failed to activate cOA
synthesis by Cmr- (Supplementary Figure S2). Neverthe-
less, even at the highest concentration tested here for this
Figure 5. Cmr--mediated ATP incorporation exhibits cooperative sub-
strate binding. Cmr- of 80 nM (A) or 20 nM (B) was incubated with
different concentration ranges of ATP for which ATP incorporation rates
(V) were determined and plotted against substrate concentrations [S] (blue
line). Error bar represents S.D. of three independent experiments. (C) The
logV versus log[S] relationship for the 80 nM Cmr- experiements (blue
dots) and 20 nM Cmr- experiments (red dots) was fitted into a linear
model: 80 nM Cmr- (blue dashed line) and 20 nM Cmr- (red dashed
line). F-test indicates the P value is <0.001 for both simulations.
enzyme (250 nM), only ∼1.0% of ATP was associated with
Cmr-, suggesting that the effector complex only has a low
affinity to ATP (Figure 6B).
Both Palm domains functioned in generation of the second
messenger c-A4
Cas10 proteins of Type III CRISPR-Cas systems
contain one HD nuclease domain and two DNA
polymerase/cyclase-like (Palm) domains (56). It has
been shown that the HD domain is responsible for the
target-RNA activated ssDNA cleavage (28–32) and that
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Figure 6. Cmr- exhibits a weak and divalent metal ion-dependent ATP
binding activity. (A) About 1 nM 32P-ATP was mixed with 200 nMCmr-
 in the presence of 1 mM EDTA or 5 mMMgCl2 and incubated at 70◦C
for 10 min. One set of these samples was supplemented with 300 nM SS1-
46 and further incubated for 3 min at 70◦C. All samples were analyzed
by non-denaturing PAGE. (B) About 1 nM 32P-ATP was incubated with
increasing concentrations of Cmr- (50, 100, 200 and 250 nM) in the pres-
ence of 5 mMMgCl2 and analyzed by non-denaturing PAGE.
the conserved GGDDmotif in the cyclase domain (Palm2)
is the active site for cOA synthesis in two III-A Csm–RNPs
(37,38). Furthermore, the structural analysis reveals that
both Palm domains are involved in coordinating nucleotide
binding (57,58). However, how the two Palm domains
could function in cOA synthesis remain to be clarified.
To test how these Cmr2 domains could affect the cOA
production, conserved amino acids in each domain were
mutated by alanine substitution (Figure 7A, Supplementary
Figure S7), and the resulting cmr2mutants were employed
for purification of the corresponding mutated Cmr- effec-
tor complexes including Cmr--Cmr2HD (H14A-D15A),
Cmr--Cmr2P2 (D667A-D668A) and Cmr--Cmr2P1
(S214A-S218A) (Supplementary Figure S8A). These Cmr-
–RNPs were analyzed for target RNA cleavage, ssDNA
cleavage and c-A4 generation activities as well as for ATP
affinity.We found that: (i) none of these mutations impaired
the backbone RNA cleavage (Supplementary Figure S8B);
(ii) the HDmutation abolished ssDNA cleavage but showed
little effect on cOA synthesis (Supplementary Figure S8C);
(iii) while the substitutions in Palm 2 essentially abolished
cOA synthesis, the Palm 1 domain substitutions strongly
impaired the cOA production (40% residual activity, Fig-
ure 7B and Supplementary Figure S9A) and (iv) while Cmr-
-Cmr2P1 exhibited 33% residual ATP binding, Cmr--
Cmr2P2 showed less influence (possessing 62% residual
ATP affinity) (Figure 7C and Supplementary Figure S9B).
Therefore, our work not only confirmed that the DD motif
in Palm 2 is the catalytic site of cA4 synthesis, in analogy
to other studied Type III CRISPR-Cas systems (37,38), but
also suggested that Palm 1 is very important in promoting
cooperative substrate binding for robust cOA production.
Figure 7. Both Palm1 and Palm2 domains of Cmr2 function in c-A4
generation. (A) Schematic of Cmr–2 domain structure. The conserved
amino acids in HD, Palm1 and Palm2 domains (subjected to mutagenesis)
are indicated. (B) Relative cOA synthesis activity of the wild-type Cmr-
–RNP (WT) and its mutant derivatives. (C) ATP binding affinity of the
wild-type Cmr-–RNP (WT) and its mutant derivatives. Cmr-HD, Cmr-
P1 and Cmr-P2: effector complexes carrying substitution mutations in
the HD, Palm 1 or Palm 2 domain of Cmr2. The amount of synthesized
cOA/bound ATP by the wild-type Cmr- complex was arbitrarily set to 1.
DISCUSSION
Here, we show that the S. islandicus Cmr- catalyzes the
synthesis of cOA second messengers with ATP and that
the ATP reaction is subjected to the regulation of target
RNA binding and cleavage, in analogy to the cOA synthe-
sis by S. thermophilus and E. italicus Csm–RNPs (37,38).
Since all tested Type III CRISPR-Cas systems possess the
target RNA-activated indiscriminate DNase activity (28–
32), altogether these data demonstrate that the multiple nu-
cleic acid interference activities and the cOA signaling are
evolutionarily conserved at least in Type III-A and III-B
CRISPR-Cas10 systems of both bacterial and archaeal ori-
gin.
Our research has also gained important insights into the
cOA synthesis mechanism by Type III CRISPR-Cas sys-
tems. First, we show that both Palm domains of Cmr2,
a Cas10 protein function in cOA synthesis. This is because
mutagenesis of Cmr2 functional domains has revealed
that, whereas the Palm 1 domain is more important in sub-
strate binding than Palm 2 (Figure 7C), the latter hosts the
active site of cOA synthesis (Figure 7B). Structural analysis
of the P. furiosus Cmr2 (PfCmr2), either alone or in com-
plex with PfCmr3 (57,58), has revealed that both Palm do-
mains interact with nucleotides: first, the two -helices in
PfCmr2 Palm 1 interact with the adenine ring of one nu-
cleotide in all three structures, occupying the same position;
second, one of the PfuCmr2-Cmr3 subcomplexes contained
two ATP molecules, in which the second ATP is present in
the Palm 2 domain (58). The higher substrate affinity and
more frequent occurrence ofATP-bound forms suggest that
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Figure 8. Amodel for Cmr--mediated c-A4 synthesis. Cmr- is represented with Palm1 (P1), Palm2 (P2) andD2 (D2) domains of the Cmr–2, three of the
five conserved domains identified in the P. furiosusCmr2 (57). Binding of the cognate target RNA to Cmr- yields a ternary Cmr- complex (A). Upon the
binding of the first ATP molecule to the ternary Cmr-, the substrate-enzyme intermediate adopts a conformational change and becomes more accessible
to a second ATPmolecule (B and C). Nucleophilic attack from the 3′-hydroxyl group (3′-OH) of the first ATP molecule to the 5′-triphosphate group (5′-P)
of the second ATP molecule yields a phosphodiester bond between the two nucleotides (D). Cmr-–RNP translocates on the 2-nt intermediate, freeing
one of the ATP-binding sites (E). The process is repeated, leading to the formation of the third and the fourth phosphodiester bond (E and F). Finally,
the substrate-free active site in Cmr- recaptures the first nucleotide of the poly-A4 RNA (F and G) and circularizes the tetraadenylate in a condensation
reaction.
Palm 1 could bind ATP first and then Palm 2, but this as-
sumption remains to be tested experimentally. Nevertheless,
these findings indicate that both Palm 1 and Palm 2 func-
tions in substrate binding and the polymerization reaction.
In addition, the conservation of the S-X-X-X-S motif in the
Palm 1 domain in a number of Cmr2 and Csm1 proteins
suggests a functional conservation in Cas10 proteins (Sup-
plementary Figure S10).
Investigation of the kinetics of Cmr--mediated cOA syn-
thesis has revealed that the ATP reaction involves coopera-
tive substrate binding (Figure 5). It has been reported that
cooperative substrate binding can facilitate enzymatic reac-
tion since the binding of the first substrate molecule to an
enzyme induces a conformational change that makes the
second substrate-binding site more accessible to substrate
molecule (59) such as diguanylate cyclases (60). We pro-
pose that Type III CRISPR-Cas could have adopted the
same mechanism in cOA synthesis as shown in the model
shown in Figure 8. Upon the binding of the cognate tar-
get RNA to a Type III effector complex, the Palm 1 site
in Cas10 proteins serves as the primary binding site of the
enzyme–substrate interaction, and the Palm 1–ATP interac-
tion induces a conformation change that allows the Palm 2
also effectively interacts with ATP to start the cOA synthe-
sis, forming the first phosphodiester bond. Then, the effec-
tor complex translocates on the 2-nt intermediate, allowing
the enzyme to interact with new incoming ATP. The process
is repeated for three times to yield the chain elongation in
the nucleotide synthesis. Finally, the complex recaptures the
first nucleotide of the oligoadenylate RNA at the last step
of the synthesis, and condensation between the 3′-hydroxyl
group of the last adenylate of the oligonucleotides and the
5′-triphosphate group of the first adenylate circularizes the
tetraadenylate, giving c-A4 (Figure 8).
Nevertheless, it remains to be investigated if other Type
III CRISPR-Cas systems have also adopted the cooperative
substrate binding mechanism in their cOA synthesis. This
is because functional diversification has already been ob-
served for Cmr and Csm systems. For example, while the
DDmotif of Palm 2 only plays a minor role in ATP binding
in the Cmr-–RNP system, suggesting that ATP molecules
bind to the effector complex even when the polymerase do-
main is in the inactive form. By contrast, the DD motif in
StCsm1 is essential for ATP binding by StCsm-RNP, the
corresponding effector complex (37). Therefore, it is inter-
esting to study if the diversification of Cmr and Csm sys-
tems could have influenced the conservation of cooperative
substrate binding in cOA synthesis.
In analogy to c-A6 synthesized by Type III-A Csm sys-
tems (37,38), the Sis-Cmr--synthesized c-A4 functions as
the secondmessenger to activate Csx1, a Cas accessory pro-
tein that has been implicated in the Cmr- DNA interfer-
ence (23). In the process of data analysis, we noticed some
striking differences in cOA synthesis and Csm6/Csx1 acti-
vation. First, Cmr-–RNP exhibits a robust c-A4 synthetic
activity, which should be stronger than that of c-A6 syn-
thesis by StCsm-RNP and EiCsm-RNP (37,38). Second,
SisCsx1 and TtCsm6 that interact with c-A4 show a rela-
tively weak RNase activity relative to StCsm6, StCsm6′ and
EiCsm6, which bind to c-A6 ((37,38) and this work). Those
data suggest a reverse relation between the rate of cOA syn-
thesis by a Type III RNP and the activation efficiency of
CARF-domain RNase by the corresponding cOA ligand.
The reverse relation might be attributed to the coevolution
of the two enzymes in the CRISPR signaling pathway such
that the intrinsic drawback of the weakened ligand–enzyme
interaction is complemented by an elevated level of ligand
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synthesis, and vice versa. Such a coevolution would ensure
a proper function of CRISPR signaling in antiviral defense.
In a previous work, we showed that RNAs carrying a
tetraadenylate tail are capable of strongly activating the in-
discriminate RNase of SisCsx1. Here, we further show that
the efficiency of the SisCsx1 activation by c-A4 is a few folds
higher than that by the linear one. Since it has been reported
that linear RNAs carrying a poly-A tail are intermediates of
the RNA decay pathway present in many prokaryotes (61),
including S. solfataricus (62,63). The finding that both lin-
ear and circular tetraadenylate can serve as a second mes-
senger to activate Csx1 has important implication in the bi-
ology of this organism.We hypothesize that the dynamic in-
teraction between poly-A-tailed RNAs and SisCsx1 could
reflect that some microorganisms have explored the cOA–
CARFdomain pathway for other stress regulation such that
cellular metabolic activity is to be greatly reduced under
stressful conditions. For example, a programmed cell death
pathway can be induced by DNA damage treatment (64),
and the induction of the programmed cell death could be
coupled to a novel type of DNA damage response regu-
lation recently been discovered in S. islandicus since lack
of DNA damage response regulation greatly facilitates cell
death (65,66). To this end, it is very tempting to investigate
whether linear and/or circular tetraadenylate could play a
role in the stress-responsive regulation in this archaeon.
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